POS-163 A RANDOMIZED CONTROL TRIAL OF RITUXIMAB VERSUS MODIFIED PONTICELLI REGIMEN IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY – A PILOT STUDY
Main Authors: | S. SURESH, A. Konnur, S. Gang, U. Hegde, H. Patel, M.M. Rajapurkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024921003193 |
Similar Items
-
POS-396 A RANDOMIZED CONTROL TRIAL OF RITUXIMAB VS MODIFIED PONTICELLI REGIMEN IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY – A PILOT STUDY
by: S. SURESH, et al.
Published: (2021-04-01) -
Study of hypothalamic pituitary adrenal axis in patients of membranous nephropathy receiving modified Ponticelli regimen
by: R Ramachandran, et al.
Published: (2015-01-01) -
Membranous Nephropathy: Pilot Study of a Novel Regimen Combining Cyclosporine and Rituximab
by: Meryl Waldman, et al.
Published: (2016-07-01) -
POS-759 HISTOLOGICAL ANALYSIS OF 3 AND 6 MONTH PROTOCOL BIOPSIES AND OUTCOME SIN ABO INCOMPATIBLE RENAL TRANSPLANTS
by: U. Hegde, et al.
Published: (2021-04-01) -
POS-732 A STUDY OF ANGIOTENSIN ii TYPE II RECEPTOR ANTIBODY IN RENAL ALLOGRAFT REJECTION
by: U. Hegde, et al.
Published: (2021-04-01)